Researchers are excited about the medication , a groundbreaking dual compound showing remarkable results in initial trials for size loss . It acts by targeting both systems: GLP-1 and GIP, which , when https://oisihzhx579328.eedblog.com/41052271/the-new-hope-for-body-management